Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas

被引:63
作者
Franke, FE
Steger, K
Marks, A
Kutzner, H
Mentzel, T
机构
[1] Univ Giessen, Dept Pathol, D-35392 Giessen, Germany
[2] Univ Giessen, Dept Vet Anat, D-35392 Giessen, Germany
[3] Dermatohistol Lab, Friedrichshafen, Germany
[4] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada
关键词
D O I
10.1111/j.0303-6987.2004.00192.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Hobnail hemangioma (targetoid hemosiderotic hemangioma) is a small benign vascular tumor of the superficial and mid-dermis. In contrast to its well-characterized histology, it has been unclear whether this tumor arises from blood vessel endothelial cells (BECs) or lymphatic vessel endothelial cells (LECs). Methods: We analyzed 10 hobnail hemangiomas by immunohistochemistry, using the recently described lymphatic endothelial cell marker, D2-40. For comparison, CD31, CD34, and alpha-smooth muscle actin expression were studied in consecutive sections of the paraffin-embedded tissues. Results:. In all analyzed vessels, D2-40 labeled exclusively LECs, whereas BECs were consistently negative. In contrast to capillary BECs, either neighboring the tumors or intermingled, neoplastic endothelial cells of all 10 hobnail hemangiomas were strongly labeled by D2-40. Conclusions: The results suggest a lymphatic origin for hobnail hemangiomas. This view is further supported by the CD34 negativity of endothelial cells and the lack of actin-labeled pericytes in hobnail hemangiomas, both characteristic of lymphatic vessels. Moreover, our analysis revealed that microshunts between neoplastic lymphatic vascular channels and small blood vessels occur, explaining some features of hobnail hemangiomas, such as aneurysmatic microstructures, erythrocytes within and beneath neoplastic vascular spaces, inflammatory changes, scarring, and interstitial hemosiderin deposits.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 23 条
  • [1] LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
    Banerji, S
    Ni, J
    Wang, SX
    Clasper, S
    Su, J
    Tammi, R
    Jones, M
    Jackson, DG
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 144 (04) : 789 - 801
  • [2] Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium
    Breiteneder-Geleff, S
    Soleiman, A
    Kowalski, H
    Horvat, R
    Amann, G
    Kriehuber, E
    Diem, K
    Weninger, W
    Tschachler, E
    Alitalo, K
    Kerjaschki, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) : 385 - 394
  • [3] RETIFORM HEMANGIOENDOTHELIOMA - A DISTINCTIVE FORM OF LOW-GRADE ANGIOSARCOMA DELINEATED IN A SERIES OF 15 CASES
    CALONJE, E
    FLETCHER, CDM
    WILSONJONES, E
    ROSAI, J
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (02) : 115 - 125
  • [4] TARGETOID HEMOSIDEROTIC HEMANGIOMA
    CRUZ, DJS
    ARONBERG, J
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (03) : 550 - 558
  • [5] Papillary intralymphalic angioendothelioma (PILA) - A report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels
    Fanburg-Smith, JC
    Michal, M
    Partanen, TA
    Alitalo, K
    Miettinen, M
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (09) : 1004 - 1010
  • [6] Vascular endothelial growth factor receptor-3 (VEGFR-3): A marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas
    Folpe, AL
    Veikkola, T
    Valtola, R
    Weiss, SW
    [J]. MODERN PATHOLOGY, 2000, 13 (02) : 180 - 185
  • [7] Hobnail hemangioma - A pseudomalignant vascular lesion with a reappraisal of targetoid hemosiderotic hemangioma
    Guillou, L
    Calonje, E
    Speight, P
    Rosai, J
    Fletcher, CDM
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (01) : 97 - 105
  • [8] A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors
    Kahn, HJ
    Marks, A
    [J]. LABORATORY INVESTIGATION, 2002, 82 (09) : 1255 - 1257
  • [9] Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas
    Kahn, HJ
    Bailey, D
    Marks, A
    [J]. MODERN PATHOLOGY, 2002, 15 (04) : 434 - 440
  • [10] EXPRESSION OF THE FMS-LIKE TYROSINE KINASE-4 GENE BECOMES RESTRICTED TO LYMPHATIC ENDOTHELIUM DURING DEVELOPMENT
    KAIPAINEN, A
    KORHONEN, J
    MUSTONEN, T
    VANHINSBERGH, VWM
    FANG, GH
    DUMONT, D
    BREITMAN, M
    ALITALO, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3566 - 3570